nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.12.2018 | editorial

BEST of ASCO 2018

verfasst von: Univ. Prof. Prim. Dr. Josef Thaler

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Excerpt

The library of the 2018 annual meeting of the American Society of Clinical Oncology (ASCO) contains 6251 contributions including a range of practice-changing presentations. A selection of major topics from this meeting were presented and discussed in the officially licensed “Best of ASCO” meeting in Vienna on June 22 and 23, 2018. Austrian experts and speakers of this meeting were invited to summarize and discuss the most important and clinically relevant data from the 2018 ASCO meeting in this special memo edition. …

Nächster Artikel Personalized prostate cancer diagnosis and treatment—are we ready?

Sonnweber B, Wöll E. ASCO update 2018: upper gastrointestinal cancer. memo. 2018. https://doi.org/10.1007/s12254-018-0447-4.CrossRef

Conroy T, Hammel P, Hebbar M, et al. Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine in patients with resected pancreatic ductal adenocarcinomas. 2018 ASCO Annual Meeting. J Clin Oncol. 2018;36(suppl):abstr LBA 4001.CrossRef

Gamerith G, Kocher F, Rudzki J, Pircher A. ASCO 2018 NSCLC highlights—combination therapy is key. memo. 2018. https://doi.org/10.1007/s12254-018-0444-7.CrossRef

Richtig E. ASCO Congress 2018: melanoma treatment. memo. 2018. https://doi.org/10.1007/s12254-018-0455-4.CrossRef

Long G, et al. ASCO 2018. 2018. https://meetinglibrary.asco.org/record/159075/abstract (Access: 11 November 2018).

Titel: BEST of ASCO 2018
verfasst von: Univ. Prof. Prim. Dr. Josef Thaler
Publikationsdatum: 01.12.2018
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 4/2018
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-018-0453-6

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

ASCO update 2018: upper gastrointestinal cancer

Educational no. 3: Cytogenetic analysis (CA)

Cure in metastatic disease: how to manage and who is the right patient in colorectal cancer?

Personalized prostate cancer diagnosis and treatment—are we ready?

ASCO 2018 NSCLC highlights—combination therapy is key

Significance of genetic polymorphisms in hematological malignancies: implications of risk factors for prognosis and relapse